Razelle Kurzrock, MD, CureMetrix Board Member, was recognized as Woman in Tech and a Woman of Influence by the San Diego Business Journal.
Razelle Kurzrock, MD, CureMetrix Board Member, was recognized as Woman in Tech and a Woman of Influence by the San Diego Business Journal.
Topics: radiology, AI, breast cancer, mammogram, cmTriage, artificial intelligence, mammography, screening, CAD, AI-CAD, Machine Learning, breast cancer awareness, AI Mammogram, black history month, Breast imaging, BI-RADS Atlas 5th Edition, FFPI, Dense Breast, Ethnic disparities, BRCA, Ashkenazi Jewish, Asian Women, Brazilian women, African American Women
Radiologists know that every patient is different. When reading a mammogram, it’s important to know a patient’s racial and ethnic background, health history, age, geographic location and breast density, just to name a few factors. Understanding how these differences may affect a patient’s diagnosis is crucial—and unfortunately, many radiologists do not have the data driven insights they need to accurately diagnose a diverse array of cases and find breast cancers earlier.
Topics: radiology, AI, breast cancer, mammogram, cmTriage, artificial intelligence, mammography, screening, CAD, AI-CAD, Machine Learning, breast cancer awareness, AI Mammogram, black history month, Breast imaging, BI-RADS Atlas 5th Edition, FFPI, Dense Breast, Ethnic disparities, BRCA, Ashkenazi Jewish, Asian Women, Brazilian women, African American Women
Coronary heart disease is the leading cause of death for women in the United States. One in three women will die from heart disease alone, according to the American Heart Association—five times the rate of death from breast cancer.
Topics: radiology, AI, breast cancer, mammogram, cmTriage, artificial intelligence, mammography, screening, CAD, AI-CAD, Machine Learning, breast cancer awareness, RSNA, AI Mammogram
Human insights and visionary medicine – the theme for the 2020 RSNA Annual Meeting, and the CureMetrix team aims to deliver just that – all in a virtual setting. Many of you have engaged already via the AI Test Drive Challenge and other events throughout the year, and we are excited to support you with education and information that can be applied in your practice to improve cancer detection, reduce false positives, and reduce reading time so that you can deliver a better patient experience.
Topics: radiology, AI, breast cancer, mammogram, cmTriage, artificial intelligence, mammography, screening, CAD, AI-CAD, Deep Learning, Machine Learning, breast cancer awareness, Athena
CureMetrix AI joins 567 projects, products, and services from Spotify, Google, Disney+, and others.
CureMetrix was honored as a finalist in Fast Company’s Innovation by Design Awards for 2020 in the Health category.
Topics: radiology, AI, breast cancer, mammogram, cmTriage, artificial intelligence, mammography, screening, CAD, AI-CAD, Deep Learning, Machine Learning, breast cancer awareness
The AI-based mammography screening paper by Google scientists first published in Nature is bringing public awareness to one of the most promising fields of artificial intelligence, presenting the perfect opportunity for CureMetrix to highlight our AI-driven mammography solutions that are already in the market saving today. Highlighted in the Journal of Digital Imaging in April 2019, CureMetrix is currently being used to support radiologists in clinics in the US, Brazil, and Mexico.
Topics: radiology, artifical intelligence, AI, google
We are honored to share the news that CureMetrix was selected by an esteemed panel of industry and clinical experts as the Best New Radiology Vendor for 2019 https://www.einpresswire.com/article/500004616/curemetrix-wins-best-new-radiology-vendor-of-the-year
Topics: Insider, News, Case Studies, radiology, Cancer Detection, artifical intelligence, AI, Best Radiology Vendor
It's here, it's empowering , and it's moving fast. To keep you informed about advances in artificial intelligence for Radiology, sign up for our blog:
© 2022, CureMetrix, Inc. All rights reserved.
Terms of Use | Privacy Policy | Disclaimer